3-41897008-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_017886.4(ULK4):​c.1349-5C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.984 in 1,604,058 control chromosomes in the GnomAD database, including 779,138 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.93 ( 66384 hom., cov: 31)
Exomes 𝑓: 0.99 ( 712754 hom. )

Consequence

ULK4
NM_017886.4 splice_region, intron

Scores

2
Splicing: ADA: 0.0002944
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.97

Publications

7 publications found
Variant links:
Genes affected
ULK4 (HGNC:15784): (unc-51 like kinase 4) This gene encodes a member of the unc-51-like serine/threonine kinase (STK) family. Members of this protein family play a role in neuronal growth and endocytosis. The encoded protein is likely involved in neurite branching, neurite elongation and neuronal migration. Genome-wide association studies (GWAS) indicate an association of variations in this gene with blood pressure and hypertension. Sequence variations in this gene may also be be associated with psychiatric disorders, including schizophrenia and bipolar disorder. Pseudogenes associated with this gene have been identified and are located on chromosome 15. [provided by RefSeq, Jul 2016]
ULK4 Gene-Disease associations (from GenCC):
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 3-41897008-G-C is Benign according to our data. Variant chr3-41897008-G-C is described in ClinVar as Benign. ClinVar VariationId is 403587.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.991 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ULK4NM_017886.4 linkc.1349-5C>G splice_region_variant, intron_variant Intron 14 of 36 ENST00000301831.9 NP_060356.2
ULK4NM_001322500.2 linkc.1349-5C>G splice_region_variant, intron_variant Intron 14 of 35 NP_001309429.1
ULK4NM_001322501.2 linkc.443-5C>G splice_region_variant, intron_variant Intron 13 of 35 NP_001309430.1
ULK4NR_136342.2 linkn.1415-5C>G splice_region_variant, intron_variant Intron 13 of 34

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ULK4ENST00000301831.9 linkc.1349-5C>G splice_region_variant, intron_variant Intron 14 of 36 2 NM_017886.4 ENSP00000301831.4
ULK4ENST00000420927.5 linkc.1349-5C>G splice_region_variant, intron_variant Intron 14 of 17 1 ENSP00000412187.1

Frequencies

GnomAD3 genomes
AF:
0.928
AC:
141195
AN:
152112
Hom.:
66356
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.760
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.964
Gnomad ASJ
AF:
0.979
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.999
Gnomad FIN
AF:
0.999
Gnomad MID
AF:
0.949
Gnomad NFE
AF:
0.997
Gnomad OTH
AF:
0.944
GnomAD2 exomes
AF:
0.979
AC:
237951
AN:
243012
AF XY:
0.984
show subpopulations
Gnomad AFR exome
AF:
0.753
Gnomad AMR exome
AF:
0.981
Gnomad ASJ exome
AF:
0.982
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.999
Gnomad NFE exome
AF:
0.996
Gnomad OTH exome
AF:
0.983
GnomAD4 exome
AF:
0.990
AC:
1437410
AN:
1451828
Hom.:
712754
Cov.:
29
AF XY:
0.991
AC XY:
715964
AN XY:
722486
show subpopulations
African (AFR)
AF:
0.740
AC:
24333
AN:
32898
American (AMR)
AF:
0.980
AC:
42218
AN:
43076
Ashkenazi Jewish (ASJ)
AF:
0.981
AC:
25358
AN:
25850
East Asian (EAS)
AF:
1.00
AC:
39605
AN:
39606
South Asian (SAS)
AF:
0.998
AC:
85653
AN:
85790
European-Finnish (FIN)
AF:
0.999
AC:
51687
AN:
51744
Middle Eastern (MID)
AF:
0.942
AC:
5375
AN:
5708
European-Non Finnish (NFE)
AF:
0.998
AC:
1104495
AN:
1107160
Other (OTH)
AF:
0.978
AC:
58686
AN:
59996
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
559
1117
1676
2234
2793
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21602
43204
64806
86408
108010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.928
AC:
141269
AN:
152230
Hom.:
66384
Cov.:
31
AF XY:
0.930
AC XY:
69221
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.760
AC:
31513
AN:
41486
American (AMR)
AF:
0.964
AC:
14739
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.979
AC:
3400
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5184
AN:
5184
South Asian (SAS)
AF:
0.999
AC:
4818
AN:
4824
European-Finnish (FIN)
AF:
0.999
AC:
10608
AN:
10622
Middle Eastern (MID)
AF:
0.946
AC:
278
AN:
294
European-Non Finnish (NFE)
AF:
0.997
AC:
67825
AN:
68036
Other (OTH)
AF:
0.945
AC:
1992
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
443
886
1330
1773
2216
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
902
1804
2706
3608
4510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.977
Hom.:
23488
Bravo
AF:
0.917
Asia WGS
AF:
0.975
AC:
3391
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.54
DANN
Benign
0.64
PhyloP100
-2.0
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00029
dbscSNV1_RF
Benign
0.048
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1717005; hg19: chr3-41938500; API